These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26474704)

  • 1. Vascular disease modeling using induced pluripotent stem cells: Focus in Hutchinson-Gilford Progeria Syndrome.
    Pitrez PR; Rosa SC; Praça C; Ferreira L
    Biochem Biophys Res Commun; 2016 May; 473(3):710-8. PubMed ID: 26474704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunction of iPSC-derived endothelial cells in human Hutchinson-Gilford progeria syndrome.
    Matrone G; Thandavarayan RA; Walther BK; Meng S; Mojiri A; Cooke JP
    Cell Cycle; 2019 Oct; 18(19):2495-2508. PubMed ID: 31411525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pluripotent stem cells to model Hutchinson-Gilford progeria syndrome (HGPS): Current trends and future perspectives for drug discovery.
    Lo Cicero A; Nissan X
    Ageing Res Rev; 2015 Nov; 24(Pt B):343-8. PubMed ID: 26474742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hutchinson-Gilford progeria syndrome as a model for vascular aging.
    Brassard JA; Fekete N; Garnier A; Hoesli CA
    Biogerontology; 2016 Feb; 17(1):129-45. PubMed ID: 26330290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Tissue Engineered Blood Vessel Model of Hutchinson-Gilford Progeria Syndrome Using Human iPSC-derived Smooth Muscle Cells.
    Atchison L; Zhang H; Cao K; Truskey GA
    Sci Rep; 2017 Aug; 7(1):8168. PubMed ID: 28811655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired LEF1 Activation Accelerates iPSC-Derived Keratinocytes Differentiation in Hutchinson-Gilford Progeria Syndrome.
    Mao X; Xiong ZM; Xue H; Brown MA; Gete YG; Yu R; Sun L; Cao K
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reprogramming progeria fibroblasts re-establishes a normal epigenetic landscape.
    Chen Z; Chang WY; Etheridge A; Strickfaden H; Jin Z; Palidwor G; Cho JH; Wang K; Kwon SY; Doré C; Raymond A; Hotta A; Ellis J; Kandel RA; Dilworth FJ; Perkins TJ; Hendzel MJ; Galas DJ; Stanford WL
    Aging Cell; 2017 Aug; 16(4):870-887. PubMed ID: 28597562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects.
    Zhang J; Lian Q; Zhu G; Zhou F; Sui L; Tan C; Mutalif RA; Navasankari R; Zhang Y; Tse HF; Stewart CL; Colman A
    Cell Stem Cell; 2011 Jan; 8(1):31-45. PubMed ID: 21185252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. iPSC-Derived Endothelial Cells Affect Vascular Function in a Tissue-Engineered Blood Vessel Model of Hutchinson-Gilford Progeria Syndrome.
    Atchison L; Abutaleb NO; Snyder-Mounts E; Gete Y; Ladha A; Ribar T; Cao K; Truskey GA
    Stem Cell Reports; 2020 Feb; 14(2):325-337. PubMed ID: 32032552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aging of Hutchinson-Gilford progeria syndrome fibroblasts is characterised by hyperproliferation and increased apoptosis.
    Bridger JM; Kill IR
    Exp Gerontol; 2004 May; 39(5):717-24. PubMed ID: 15130666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomechanical Strain Exacerbates Inflammation on a Progeria-on-a-Chip Model.
    Ribas J; Zhang YS; Pitrez PR; Leijten J; Miscuglio M; Rouwkema J; Dokmeci MR; Nissan X; Ferreira L; Khademhosseini A
    Small; 2017 Apr; 13(15):. PubMed ID: 28211642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced pluripotent stem cells reveal functional differences between drugs currently investigated in patients with hutchinson-gilford progeria syndrome.
    Blondel S; Jaskowiak AL; Egesipe AL; Le Corf A; Navarro C; Cordette V; Martinat C; Laabi Y; Djabali K; de Sandre-Giovannoli A; Levy N; Peschanski M; Nissan X
    Stem Cells Transl Med; 2014 Apr; 3(4):510-9. PubMed ID: 24598781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hutchinson-Gilford progeria syndrome.
    Ullrich NJ; Gordon LB
    Handb Clin Neurol; 2015; 132():249-64. PubMed ID: 26564085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective extracellular pyrophosphate metabolism promotes vascular calcification in a mouse model of Hutchinson-Gilford progeria syndrome that is ameliorated on pyrophosphate treatment.
    Villa-Bellosta R; Rivera-Torres J; Osorio FG; Acín-Pérez R; Enriquez JA; López-Otín C; Andrés V
    Circulation; 2013 Jun; 127(24):2442-51. PubMed ID: 23690466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody.
    McClintock D; Gordon LB; Djabali K
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2154-9. PubMed ID: 16461887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hutchinson-Gilford progeria syndrome: Rejuvenating old drugs to fight accelerated ageing.
    Guilbert SM; Cardoso D; Lévy N; Muchir A; Nissan X
    Methods; 2021 Jun; 190():3-12. PubMed ID: 32278808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation.
    Blondel S; Egesipe AL; Picardi P; Jaskowiak AL; Notarnicola M; Ragot J; Tournois J; Le Corf A; Brinon B; Poydenot P; Georges P; Navarro C; Pitrez PR; Ferreira L; Bollot G; Bauvais C; Laustriat D; Mejat A; De Sandre-Giovannoli A; Levy N; Bifulco M; Peschanski M; Nissan X
    Cell Death Dis; 2016 Feb; 7(2):e2105. PubMed ID: 26890144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hutchinson-Gilford progeria syndrome through the lens of transcription.
    Prokocimer M; Barkan R; Gruenbaum Y
    Aging Cell; 2013 Aug; 12(4):533-43. PubMed ID: 23496208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Potential of iPSCs for the Treatment of Premature Aging Disorders.
    Compagnucci C; Bertini E
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29112121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro pathological modelling using patient-specific induced pluripotent stem cells: the case of progeria.
    Nissan X; Blondel S; Peschanski M
    Biochem Soc Trans; 2011 Dec; 39(6):1775-9. PubMed ID: 22103524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.